REFERENCES
- Moschcowitz, E. Hyaline thrombosis of the terminal arterioles and
capillaries: a hitherto undescribed disease. Proc. N. Y. Pathol. Soc.
24, 21–24 (1924).
- Soejima, K. et al. A novel human metalloprotease synthesized in the
liver and secreted into the blood: possibly, the von Willebrand
factor-cleaving protease? J. Biochem. 130, 475–480 (2001).
- Schulman, I., Pierce, M., Lukens, A. & Currimbhoy, Z. Studies on
thrombopoiesis. I: a factor in normal human plasma required for
platelet production; chronic thrombocytopenia due to its deficiency.
Blood 16, 943–957 (1960). 17.
- Upshaw, J. D. Congenital deficiency of a factor in normal plasma that
reverses microangiopathic hemolysis and thrombocytopenia. N. Engl.
J. Med. 298, 1350–1352 (1978).
- Scully, M. et al. Guidelines on the diagnosis and management of
thrombotic thrombocytopenic purpura and other thrombotic
microangiopathies. Br. J. Haematol. 158, 323–335 (2012). 106.
- Matsumoto, M. et al. Acquired idiopathic ADAMTS13 activity deficient
thrombotic thrombocytopenic purpura in a population from Japan. PLoS
ONE 7, e33029 (2012).
- Rock, G. A. et al. Comparison of plasma exchange with plasma infusion
in the treatment of thrombotic thrombocytopenic purpura. Canadian
Apheresis Study Group. N. Engl. J. Med. 325, 393–397 (1991).
- Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving
protease in acute thrombotic thrombocytopenic purpura. N Engl J Med.
1998;339 (22):1585-1594. [PMC free article] [PubMed] [Google
Scholar]
- Tsai, HM.; Chapter 49: Thrombotic Thrombocytopenic purpura,
Hemolytic-Uremic Syndrome, and Related Disorders. In Wintrobe,s
Clinical Hematology, 14th ed.; Greer, J.P., Glader,
B.E., List, A.F., Means, R.M, Rodgers, G.M., Eds.; Wolters Kluwer:
Philadelphia, PA, USA, 2019; pp. 3434-3510
- Tsai HM. Pathophysiology of thrombotic thrombocytopenic purpura. Int J
Hematol. 2010;91(1):1-19
- Arboix A, Besses C. Cerebrovascular disease as the initial clinical
presentation of haematological disorders. Eur Neurol.
1997;37(4):207-211.
- Burrus TM, Wijdicks EF, Rabinstein AA. Brain lesions are most often
reversible in acute thrombotic thrombocytopenic purpura. Neurology.
2009;73(1):66-7
- Tsai HM. The molecular biology of thrombotic microangiopathy. Kidney
Int. 2006;70(1):16
- Tanner L. Muller MM. [Blood Transfusion: a guide to Clinical
Decision making] Anasthesiol Intensivmed Notfallmed Schmerzther.
2019 Mar;54(3): 194-205. [PubMed]
- Coppo P, Cuker A, George JN. Thrombotic thrombocytopenic purpura:
Toward targeted therapy and precision medicine. Res Pract Thromb
Haemost. 2019 Jan; 3(1):26-37 [PMC free article] [PubMed}
- Wiernek SL, Jiang B, Gustafson GM, Dai X. cardiac implications of
thrombotic thrombocytopenic purpura. World J Cardiol. 2018 Dec
26;10(12):254-266. [PMC free article] [PubMed]
- Bendapudi PK, Huwitz S, Fry A, Marques MB, Waldo SW, Li A, et al.
Derivation and external validation of the PLASMIC score for rapid
assessment with thrombotic microangiopathies: a cohort study. Lancet
Haematol. 2017; 4:157-64.
- Bendapuli PK, Makar RS. An algorithmic approach to the diagnosis and
management of the thrombotic microangiopathies. Am J Clin Pathol.
2016; 145:152-4
- Polito MG, Kirsztajn GM. Thrombotic microangiopathies: thrombotic
thrombocytopenic purpura / hemolytic uremic syndrome. J Bras Nefrol.
2010;32(3):303-315. 24.
- Kiss JE. Thrombotic thrombocytopenic purpura: recognition and
management. Int J Hematol. 2010;91(1):36-45
- Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC,
Spasoff RA. Comparison of plasma exchange with plasma infusion in the
treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis
Study Group. N Engl J Med. 1991;325(6):393-397
- Kiss JE. Thrombotic thrombocytopenic purpura: recognition and
management. Int J Hematol. 2010;91(1):36-45.
- George JN, Woodson RD, Kiss JE, Kojouri K, Vesely SK. Rituximab
therapy for thrombotic thrombocytopenic purpura: a proposed study of
the Transfusion Medicine/Hemostasis Clinical Trials Network with a
systematic review of rituximab therapy for immune-mediated disorders.
J Clin Apher. 2006;21(1):49-56.
- Cataland SR, Jin M, Ferketich AK, Kennedy MS, Kraut EH, George JN, Wu
HM. An evaluation of cyclosporin and corticosteroids individually as
adjuncts to plasma exchange in the treatment of thrombotic
thrombocytopenic purpura. Br J Haematol. 2007;136(1):146-149.